CVS Health Corp (CVS) Stock Forecast & Predictions

CVS Health Corp CVS: $76.18

1 Cvs Dr, Woonsocket, Rhode Island, US. | Sector: Retail Trade | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: https://cvshealth.com/

  • Market Cap$99.93B
  • Change (52 Weeks)30.04%
  • Low (52 Weeks)$54.63
  • CVS Health Corp (CVS) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 31.25% are on Buy, 18.75% on Sell, and 50.00% Neutral.

    According to the market data, CVS Health Corp (CVS) stock price is $76.18 and the 52 weeks low is $54.63, which means the CVS Health Corp stock price is up 30.04% in the last 12 months.

    CVS Health Corp (CVS) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 31.25% are indicating that CVS Stock price might rise further, 18.75% indicating that CVS Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall CVS stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    CVS Health Corp (CVS) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for CVS Health Corp (CVS) is based on 32 Institutional Analyst Ratings where 50.00% are on Strong Buy, 21.88% on Moderate Buy, 28.13% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 32 Institutional Analysts, majority recommended CVS stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of CVS Health Corp.

    CVS Health Corp (CVS) Stock Price Prediction By Analysts


    HighLowAverage
    $107.10$72.72$88.92
    $88.9216.73% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for CVS set by the institutional analysts is $88.92 where High Estimate is $107.10, Median $89.76 and Low $72.72.

    The average price target for CVS by Institutional Analysts is $88.92, which is 16.73% Upside from the current price. So according to the Institutional Analysts, CVS Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    CVS Health Corp (CVS) Stock Forecast Based on News Sentiment


    Bullish
    Based on 20 articles published Last Week, where 100.00% are Bullish and 0.00% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked positively about CVS, it shows that CVS Health Corp had a 100.00% positive news coverage.

    Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that CVS stock price may surge in the next few weeks.

    CVS Health Corp (CVS) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Truist SecuritiesBuyMaintained
    Morgan StanleyOverweightMaintained
    GuggenheimNeutralDowngraded
    JefferiesBuyUpgraded
    SVB LeerinkMarket PerformMaintained
    Piper SandlerOverweightInitiated
    Credit SuisseOutperformMaintained
    SVB LeerinkMarket PerformMaintained
    SVB LeerinkMarket PerformInitiated
    Credit SuisseOutperformUpgraded
    UBSBuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    BairdNeutralMaintained
    JP MorganOverweightMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    BairdNeutralMaintained
    Deutsche BankBuyMaintained
    CitigroupBuyMaintained
    UBSBuyMaintained
    CFRAStrong BuyMaintained
    Cantor FitzgeraldOverweightMaintained
    BairdNeutralMaintained
    CFRAStrong BuyMaintained
    Raymond JamesStrong BuyReiterated
    Morgan StanleyOverweightMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Wells FargoMarket PerformMaintained
    UBSBuyMaintained
    Raymond JamesStrong BuyMaintained
    CitigroupBuyMaintained
    CitiBuyMaintained
    BarclaysOverweightMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankBuyInitiated
    Bank of AmericaBuyMaintained
    Cowen & Co.OutperformReiterated
    UBSBuyMaintained
    Morgan StanleyOverweightMaintained
    Raymond JamesStrong BuyMaintained
    GuggenheimBuyInitiated
    OppenheimerPerformDowngraded
    BMO CapitalOutperformInitiated
    BernsteinOutperformInitiated
    CitigroupBuyMaintained
    UBSBuyMaintained
    UBSBuyInitiated
    BarclaysOverweightInitiated
    Cantor FitzgeraldOverweightInitiated
    Wolfe ResearchPeer PerformInitiated
    Bank of AmericaBuyMaintained
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    Bank of AmericaBuyMaintained
    CitigroupNeutralMaintained
    Leerink SwannOutperformMaintained
    BairdNeutralMaintained
    Morgan StanleyOverweightUpgraded
    Raymond JamesStrong BuyUpgraded
    Deutsche BankBuyInitiated
    CitigroupNeutralMaintained
    NeedhamBuyUpgraded
    Loop CapitalHoldMaintained
    Leerink SwannOutperformMaintained
    JefferiesHoldMaintained
    CitigroupNeutralMaintained
    RBC CapitalOutperformInitiated
    JefferiesHoldMaintained
    Loop CapitalHoldInitiated
    CitigroupNeutralMaintained
    Wolfe ResearchPeer PerformDowngraded
    NeedhamHoldInitiated
    Tigress FinancialBuyInitiated
    Tigress FinancialBuyInitiated
    BairdNeutralDowngraded
    UBSBuyInitiated
    Bank of AmericaBuyMaintained
    BairdOutperformMaintained
    CitigroupNeutralMaintained
    Deutsche BankHoldMaintained
    Morgan StanleyEqual-WeightDowngraded
    JefferiesBuyMaintained
    CitigroupNeutralMaintained
    Atlantic EquitiesOverweightInitiated
    BairdOutperformInitiated
    Goldman SachsNeutralDowngraded
    OppenheimerOutperformMaintained
    JP MorganOverweightMaintained
    OppenheimerOutperformMaintained
    OppenheimerOutperformInitiated
    Cowen & Co.OutperformMaintained
    MacquarieOutperformInitiated
    JefferiesBuyMaintained
    Deutsche BankHoldMaintained
    CitigroupNeutralMaintained
    Goldman SachsBuyUpgraded
    JP MorganOverweightMaintained
    Bank of AmericaBuyMaintained
    SunTrust Robinson HumphreyBuyUpgraded
    JP MorganOverweightMaintained
    Credit SuisseOutperformMaintained
    BarclaysOverweightMaintained
    CitigroupNeutralInitiated
    FBR CapitalOutperformMaintained
    Deutsche BankHoldMaintained
    Cowen & Co.OutperformUpgraded
    JP MorganOverweightMaintained
    BarclaysOverweightMaintained
    BarclaysOverweightMaintained
    ISI GroupStrong BuyUpgraded
    Leerink SwannOutperformInitiated
    Deutsche BankHoldMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseOutperformMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankHoldInitiated
    BMO CapitalOutperformMaintained
    JefferiesBuyInitiated
    Cowen & Co.Market PerformInitiated
    Cantor FitzgeraldHoldDowngraded
    Wells FargoOutperformInitiated
    CitigroupBuyMaintained
    Goldman SachsNeutralMaintained
    Goldman SachsNeutralDowngraded
    JefferiesBuyMaintained
    UBSBuyMaintained
    Morgan StanleyOverweightMaintained
    MacquarieOutperformUpgraded
    JP MorganOverweightMaintained
    Credit SuisseOutperformMaintained
    Cantor FitzgeraldBuyMaintained
    ISI GroupOverweightMaintained
    JefferiesBuyMaintained
    BMO CapitalOutperformMaintained
    BarclaysOverweightMaintained
    JefferiesBuyMaintained
    ISI GroupOverweightMaintained
    Cantor FitzgeraldBuyInitiated
    JP MorganOverweightMaintained
    JefferiesBuyMaintained
    CitigroupBuyMaintained
    ISI GroupOverweightMaintained
    ISI GroupOverweightInitiated
    UBSBuyMaintained
    JefferiesBuyMaintained
    BMO CapitalMarket PerformDowngraded
    Morgan StanleyOverweightMaintained
    UBSBuyMaintained
    Goldman SachsBuyMaintained
    CitigroupBuyMaintained

    CVS Health Corp (CVS) Stock Earning Per Share (EPS) Forecast / Estimate


    $1.885
    The average consensus EPS for CVS is $1.885 with a high estimate of $2.121 and Low of $1.607 for the period 2021-06-30 and based on 21 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $1.66$1.34374442020-09-30


    The latest average Earning Per Share Estimate for CVS Health Corp is $1.88, which is higher than CVS's last EPS, $1.66. This means that Analysts are expecting CVS Health Corp to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of CVS Health Corp.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $1.66$1.34374442020-09-30
    $2.64$1.94780520000000012020-06-30
    $1.91$1.64317912020-03-31
    $1.73$1.69978962019-12-31
    $1.84$1.78656882019-09-30
    $1.89$1.71098040000000022019-06-30
    $1.62$1.51789870000000022019-03-31
    $2.14$2.07032832018-12-31
    $1.73$1.72979672018-09-30
    $1.69$1.62630200000000012018-06-30
    $1.48$1.42333242018-03-31
    $1.92$1.90545590000000022017-12-31
    $1.5$1.49951670000000032017-09-30
    $1.33$1.32042352017-06-30
    $1.17$1.11302000000000012017-03-31
    $1.71$1.68512442016-12-31
    $1.59$1.5833772016-09-30
    $1.32$1.31585832016-06-30
    $1.18$1.17221610000000022016-03-31
    $1.53$1.54767350000000012015-12-31
    $1.28$1.30631382015-09-30
    $1.22$1.20724292015-06-30
    $1.14$1.08834572015-03-31
    $1.21$1.21529262014-12-31
    $1.15$1.14528952014-09-30
    $1.13$1.10801042014-06-30
    $1.02$1.05479352014-03-31
    $1.12$1.12238272013-12-31
    $1.05$1.03042222013-09-30
    $0.97$0.96914552013-06-30
    $0.83$0.80205112013-03-31
    $1.14$1.1134242012-12-31
    $0.85$0.846382012-09-30
    $0.81$0.80522250000000012012-06-30
    $0.65$0.63635052012-03-31
    $0.89$0.90111192011-12-31
    $0.7$0.68175000000000012011-09-30
    $0.65$0.6509452011-06-30
    $0.57$0.55983292011-03-31
    $0.8$0.79652642010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).